ARWR
Price
$14.04
Change
+$0.15 (+1.08%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
1.85B
7 days until earnings call
IKT
Price
$2.23
Change
-$0.03 (-1.33%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
167.27M
Ad is loading...

ARWR vs IKT

Header iconARWR vs IKT Comparison
Open Charts ARWR vs IKTBanner chart's image
Arrowhead Pharmaceuticals
Price$14.04
Change+$0.15 (+1.08%)
Volume$33.26K
Capitalization1.85B
Inhibikase Therapeutics
Price$2.23
Change-$0.03 (-1.33%)
Volume$400
Capitalization167.27M
ARWR vs IKT Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. IKT commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and IKT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (ARWR: $13.87 vs. IKT: $2.27)
Brand notoriety: ARWR: Notable vs. IKT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 93% vs. IKT: 93%
Market capitalization -- ARWR: $1.85B vs. IKT: $167.27M
ARWR [@Biotechnology] is valued at $1.85B. IKT’s [@Biotechnology] market capitalization is $167.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, IKT is a better buy in the long-term than ARWR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 5 TA indicator(s) are bullish while IKT’s TA Score has 5 bullish TA indicator(s).

  • ARWR’s TA Score: 5 bullish, 3 bearish.
  • IKT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ARWR and IKT are a good buy in the short-term.

Price Growth

ARWR (@Biotechnology) experienced а +6.61% price change this week, while IKT (@Biotechnology) price change was +4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was -7.74%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

IKT is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($1.85B) has a higher market cap than IKT($167M). ARWR YTD gains are higher at: -26.223 vs. IKT (-30.308). IKT has higher annual earnings (EBITDA): -20.04M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. IKT (3.24M). IKT has less debt than ARWR: IKT (145K) vs ARWR (525M). ARWR has higher revenues than IKT: ARWR (2.5M) vs IKT (0).
ARWRIKTARWR / IKT
Capitalization1.85B167M1,108%
EBITDA-580.69M-20.04M2,898%
Gain YTD-26.223-30.30887%
P/E RatioN/AN/A-
Revenue2.5M0-
Total Cash553M3.24M17,047%
Total Debt525M145K362,069%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRIKT
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYZCX109.32N/A
N/A
Rydex Precious Metals C
CWVIX25.45N/A
N/A
Calvert International Equity I
PMBPX42.85N/A
N/A
Principal MidCap R5
PCBAX14.60N/A
N/A
BlackRock Tactical Opportunities Inv A
TCFSCV9.30-0.05
-0.53%
Thrivent Core Small Cap Value

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+2.97%
DNLI - ARWR
56%
Loosely correlated
+0.91%
NTLA - ARWR
55%
Loosely correlated
+7.93%
RGNX - ARWR
53%
Loosely correlated
+2.07%
BEAM - ARWR
52%
Loosely correlated
+1.01%
VERV - ARWR
50%
Loosely correlated
+3.39%
More